Wolverine Trading, LLC Lantheus Holdings, Inc. Call Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$77.7 - $123.62 $209,790 - $333,774	2,700 Added 23.08%	14,400 $1.58 Million
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $429,751 - $606,265	-7,300 Reduced 38.42%	11,700 $939,000
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $306,420 - $409,560	-6,000 Reduced 24.0%	19,000 $1.18 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $911,840 - $1.28 Million	16,400 Added 190.7%	25,000 $1.55 Million
Q3 2023 Nov 15, 2023	SELL	$60.27 - $90.75 $518,322 - $780,450	-8,600 Reduced 50.0%	8,600 $597,000
Q2 2023 Aug 23, 2023	BUY	$82.41 - $99.65 $1.42 Million - $1.71 Million	17,200 New	17,200 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$24.23 - $28.59 $208,378 - $245,874	-8,600 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$19.51 - $27.64 $167,786 - $237,704	8,600 New	8,600 $237,000
Q4 2019 Feb 12, 2020	SELL	$18.47 - $24.03 $153,301 - $199,449	-8,300 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$21.01 - $28.94 $16,808 - $23,152	800 Added 10.67%	8,300 $210,000
Q2 2019 Aug 20, 2019	BUY	$23.33 - $28.3 $174,975 - $212,250	7,500 New	7,500 $212,000

540

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.22B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.